These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5602195)

  • 21. Piretanide: effective diuretic in renal failure.
    George CR
    Med J Aust; 1981 Jan; 1(2):83-4. PubMed ID: 7015088
    [No Abstract]   [Full Text] [Related]  

  • 22. Anabolic and androgenic effects of methandrostenolone ("Nerobol") during systematic physical activity in rats.
    Rogozkin V
    Br J Sports Med; 1975 Jul; 9(2):65-9. PubMed ID: 171022
    [No Abstract]   [Full Text] [Related]  

  • 23. [Types of ventilatory insufficiency in chronic kidney insufficiency].
    Peneva S
    Vutr Boles; 1980; 19(2):75-82. PubMed ID: 7385805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [State of blood coagulation system during use of nerobol in patients with rheumatism].
    Grigor'ian VA; Furtel' VA
    Vrach Delo; 1976 Apr; (4):74-5. PubMed ID: 1087504
    [No Abstract]   [Full Text] [Related]  

  • 25. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.
    Nair S; Eason J; Loss G
    Liver Transpl; 2003 Feb; 9(2):126-9. PubMed ID: 12548505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M; Pawlak K; Myśliwiec M; Popławski A
    Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Procainamide in renal failure].
    Ochotny R; Michałowska D; Lowicki Z; Chmara E
    Pol Tyg Lek; 1983 Oct; 38(41):1281-3. PubMed ID: 6672805
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
    Ponticelli C; Locatelli F; Graziani G
    Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of renal reabsorption of bicarbonates in the pathogenesis of acidosis in chronic renal insufficiency].
    Bartoli E; Molaschi M; Chiesa A; Matone S; Pupita F
    Boll Soc Ital Biol Sper; 1967 Jun; 43(12):724-7. PubMed ID: 6080727
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of iron overload in patients with renal failure.
    Tisher CC; Barnett BM; Finch CA; Scribner BH
    Clin Sci; 1967 Dec; 33(3):539-48. PubMed ID: 6078518
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
    Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure.
    Fröhling PT; Kokot F; Schmicker R; Kaschube I; Lindenau K; Vetter K
    Clin Nephrol; 1983 Oct; 20(4):212-5. PubMed ID: 6641029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histopathological aspects of the kidney in terminal chronic renal insufficiency].
    Soler Amigó J; Vidal MT; Capdevila L; Brulles A; Rodríguez JA; Piera L
    Rev Clin Esp; 1981 Apr; 161(1):25-9. PubMed ID: 7255813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nicotinic acid and miskleron on the lipid spectrum in chronic kidney failure].
    Pyrig LA; Petrun' NM; Mel'man NIa; Nikulina GG; Shinkarenko NR
    Urol Nefrol (Mosk); 1981; (3):42-5. PubMed ID: 7268975
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antihypertensive therapy in chronic kidney failure. Comparison of pharmacologic effect of metolazone and furosemide].
    Groth H; Vetter H; Kuhlmann U; Burger R; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1983 Nov; 72(45):1423-7. PubMed ID: 6361725
    [No Abstract]   [Full Text] [Related]  

  • 36. High serum enalaprilat in chronic renal failure.
    Elung-Jensen T; Heisterberg J; Kamper AL; Sonne J; Strandgaard S; Larsen NE
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):240-5. PubMed ID: 11881130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fasting and anabolics].
    Krízek V; Stĕpánek P; Sadílek L
    Cas Lek Cesk; 1969; 108(19):567-71. PubMed ID: 5768145
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dosage bumetanide in patients with chronic renal failure and severe nephrotic syndrome.
    Koene RA
    Neth J Med; 1983; 26(9):262-5. PubMed ID: 6656977
    [No Abstract]   [Full Text] [Related]  

  • 40. [The anabolic and androgenic effect of methandrostenolone in experiments with male rats].
    Iodaev NA; Pokrovskiĭ BV
    Vopr Med Khim; 1966; 12(5):527-32. PubMed ID: 6000175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.